Cargando…
A Human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine
A high throughput histology (microTMA) platform was applied for testing drugs against tumors in a novel 3D heterotypic glioblastoma brain sphere (gBS) model consisting of glioblastoma tumor cells, iPSC-derived neurons, glial cells and astrocytes grown in a spheroid. The differential responses of gBS...
Autores principales: | Plummer, Simon, Wallace, Stephanie, Ball, Graeme, Lloyd, Roslyn, Schiapparelli, Paula, Quiñones-Hinojosa, Alfredo, Hartung, Thomas, Pamies, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363784/ https://www.ncbi.nlm.nih.gov/pubmed/30723234 http://dx.doi.org/10.1038/s41598-018-38130-0 |
Ejemplares similares
-
Engineering considerations of iPSC-based personalized medicine
por: Park, Sangbae, et al.
Publicado: (2023) -
Microglia Increase Inflammatory Responses in iPSC-Derived Human BrainSpheres
por: Abreu, Celina Monteiro, et al.
Publicado: (2018) -
Nanomedicine-Based Neuroprotective Strategies in Patient Specific-iPSC and Personalized Medicine
por: Jang, Shih-Fan, et al.
Publicado: (2014) -
iPSC Bioprinting: Where are We at?
por: Romanazzo, Sara, et al.
Publicado: (2019) -
A multimodal iPSC platform for cystic fibrosis drug testing
por: Berical, Andrew, et al.
Publicado: (2022)